CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale EVP Research & Development sold 3,500 shares at $62.93 ($220,255)
- 4 Planned sale President & CEO sold 7,500 shares at $62.81 ($471,075)
- 4 Grant or award Director acquired 97 shares (grant or award)
- 4 Grant or award Director acquired 195 shares (grant or award)
- 4 Grant or award Director acquired 195 shares (grant or award)
- 4 Grant or award Director acquired 195 shares (grant or award)
- 4 Grant or award Director acquired 97 shares (grant or award)
- 4 Grant or award Director acquired 352 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Planned sale EVP Research & Development sold 3,500 shares at $64.01 ($224,035)
- 4 Planned sale President & CEO sold 7,500 shares at $62.88 ($471,600)
- 144 Insider Sale of Securities
- 4 Planned sale EVP Research & Development sold 3,500 shares at $61.38 ($214,830)
- 4 Planned sale President & CEO sold 7,500 shares at $65.46 ($490,950)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $68.29 ($239,015)
- 144 Insider Sale of Securities
Page 1 of 127 · 2,533 filings